{"id":"NCT01000311","sponsor":"Novartis Vaccines","briefTitle":"A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 Months","officialTitle":"A Phase 3, Randomized, Open Label, Controlled Multicenter Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 Months","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-11","primaryCompletion":"2011-11","completion":"2011-11","firstPosted":"2009-10-23","resultsPosted":"2014-03-26","lastUpdate":"2014-04-21"},"enrollment":529,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Meningococcal Disease"],"interventions":[{"type":"BIOLOGICAL","name":"MenACWY-CRM","otherNames":[]},{"type":"BIOLOGICAL","name":"DTaP-IPV/Hib","otherNames":["Combined diphtheria, tetanus toxoid, acellular pertussis and inactivated polio vaccine containing Haemophilus influenzae type B vaccine; Pentacel"]},{"type":"BIOLOGICAL","name":"HBV","otherNames":["Hepatitis B virus vaccine; Engerix-B"]},{"type":"BIOLOGICAL","name":"PCV","otherNames":["Heptavalent Streptococcus pneumonia vaccine; Prevnar (PCV-7); Prevnar 13 (PCV-13)"]},{"type":"BIOLOGICAL","name":"MMR","otherNames":["Measles, mumps, and rubella vaccine; M-M-R II"]}],"arms":[{"label":"MenACWY-CRM + Routine Vaccines","type":"EXPERIMENTAL"},{"label":"Routine Vaccines","type":"EXPERIMENTAL"}],"summary":"This Phase 3 study is designed to demonstrate the safety and immunogenicity of MenACWY and non-interference of concomitant routine vaccines by MenACWY in an infant age group.","primaryOutcome":{"measure":"Percentage of Subjects With hSBA Titer â‰¥1:8 Against Serogroup A, C, W and Y One Month After Toddler Vaccination of MenACWY-CRM","timeFrame":"Baseline and one month after fourth-dose of MenACWY-CRM","effectByArm":[{"arm":"MenACWY-CRM + Routine Vaccines","deltaMin":2,"sd":null},{"arm":"Routine Vaccines","deltaMin":1,"sd":null}],"pValues":[{"comp":"OG000","p":null},{"comp":"OG000","p":null},{"comp":"OG000","p":null},{"comp":"OG000","p":null}]},"eligibility":{"minAge":"55 Days","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":46,"countries":["United States","Australia","Canada"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":21,"n":255},"commonTop":["Upper respiratory tract infection","Otitis media","Conjunctivitis","Pyrexia","Viral infection"]}}